ArticleCancer pathogenesis and therapy2023

Clinical characteristics and treatment outcomes of Chinese diffuse large B-cell lymphoma patients in the era of rituximab (2005-2018).

Yuankai Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.